CC 1065

from Streptomyces zelensis; structure in second sourc

Also Known As:

Benzo(1,2-b:4,3-b')dipyrrole-3(2H)-carboxamide, 7-((1,6-dihydro-4-hydroxy-5-methoxy-7-((4,5,8,8a-tetrahydro-7-methyl-4-oxocyclopropa(c)pyrrolo(3,2-e)indol-2(1H)-yl)carbonyl)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1,6-dihydro-4-hydroxy-5-methox; CC-1065; NSC 298223

Networked: 27 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - Duocarmycins: 63
        CC 1065: 27
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Duocarmycins: 63
        CC 1065: 27

Experts

1.	Larrick, James W: 3 articles (04/2003 - 01/2001)
2.	Wang, Hong: 3 articles (04/2003 - 01/2001)
3.	Wang, Yuqiang: 3 articles (04/2003 - 01/2001)
4.	Wright, Susan C: 3 articles (04/2003 - 01/2001)
5.	Yuan, Huiling: 3 articles (04/2003 - 01/2001)
6.	Krewer, Birgit: 2 articles (03/2009 - 01/2007)
7.	Tietze, Lutz F: 2 articles (03/2009 - 01/2007)
8.	Lee, Moses: 1 article (01/2015)
9.	Patil, Pravin C: 1 article (01/2015)
10.	Satam, Vijay: 1 article (01/2015)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2001 - "In the search for compounds with better antitumor selectivity and DNA sequence specificity many CC-1065 analogs have been synthesized in an attempt to avoid the undesired side effects while retaining its potency against tumor cells. " 01/01/1995 - "The above results demonstrate that single intravenous doses of (+)- CC-1065 and (-)-CC-1065 which cause chromosomal damage in CD-1 mice also induce an increased incidence of lung tumors in A/J mice.(ABSTRACT TRUNCATED AT 250 WORDS)" 01/01/1995 - "(-)-CC-1065 at 8 micrograms/kg induced 0.67 +/- 0.15 tumors/mouse and resulted in slightly smaller increases in the tumor incidence and multiple tumor incidence, compared to (+)-CC-1065. " 01/01/1995 - "(+)-CC-1065 induced a significant (P < or = 0.05), three-fold increase in the number of lung tumors/mouse in strain A/J mice from 0.27 +/- 0.15 for vehicle control animals to 0.83 +/- 0.15 24 weeks following a single intravenous dose of 8 micrograms/kg. This effect was paralleled by corresponding threefold increases in the percentage of mice with tumors and the percentage of mice with multiple tumors, compared to vehicle controls. " 12/01/1987 - "A series of analogs with simplified but closely related structures were chosen for this investigation because some were found to be superior to CC-1065 in the treatment of several experimental tumors. "
2.	Experimental Melanoma 04/15/1990 - "Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184." 09/01/1983 - "It is lethal to B16 and CHO cells and to a variety of human tumors in the clonogenic assay at 1 ng/ml and is effective against L1210 leukemia and B16 melanoma in vivo at 1 to 50 micrograms/kg. CC-1065 inhibits DNA synthesis and binds to DNA in a nonintercalative manner in the minor groove. "
3.	Leukemia L1210 04/15/1989 - "CC-1065 is a potent antitumor antibiotic which is cytotoxic to P388 and L1210 leukemia cells in vitro and in vivo. " 09/01/1983 - "It is lethal to B16 and CHO cells and to a variety of human tumors in the clonogenic assay at 1 ng/ml and is effective against L1210 leukemia and B16 melanoma in vivo at 1 to 50 micrograms/kg. CC-1065 inhibits DNA synthesis and binds to DNA in a nonintercalative manner in the minor groove. "
4.	Decompression Sickness (Bends) 05/15/1992 - "As a consequence of covalent modification with (+)-CC-1065, the helix bends into the minor groove and also undergoes winding and stiffening. " 03/17/1992 - "As a consequence of covalent modification with (+)-CC-1065, the DNA helix bends into the minor groove and also undergoes winding and stiffening [Lee, C.-S., Sun, D., Kizu, R., & Hurley, L. " 09/11/1993 - "To probe the directionality and locus of these A-protein-induced bends, we have used the antitumor antibiotic (+)-CC-1065 as a structural probe. " 08/20/1996 - "We have used various chemical probes [(+)-CC-1065, a minor-groove-specific agent that alkylates N3 of adenine and traps bends into the minor groove; pluramycin, a minor-major-groove threading intercalator that alkylates N7 of guanine; KMnO4, which reacts more strongly with bases in denatured DNA] to gain more information on the interaction of IHF with the H' site of phage lambda. "
5.	Leukemia 12/01/1987 - "A similar situation was true in terms of their in vivo potency; however, U-68,415 was superior to CC-1065 in terms of anti-P388 leukemia activity. " 04/03/2003 - "Glucuronide derivatives of CBI-bearing CC-1065 analogues have been synthesized, and their cytotoxicities tested against U937 leukemia cells. " 01/01/2001 - "RESULTS: A CC-1065 analogue was conjugated to a cephalosporin affording prodrug 2. The prodrug and its corresponding free drug, 1, have IC50 values of 0.9 and 0.09 nM, respectively, against U937 leukemia cells in vitro. "

Related Drugs and Biologics

1.	DNA (Deoxyribonucleic Acid)
2.	Anti-Bacterial Agents (Antibiotics)
3.	Antineoplastic Agents (Antineoplastics)
4.	Prodrugs
5.	Duocarmycins
6.	adozelesin
7.	Enzymes
8.	Alkylating Agents
9.	Cytostatic Agents
10.	Glucuronides

Related Therapies and Procedures

1.	Therapeutics

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Application Error

An application error has occurred and our support engineers have been notified.

Please use the browser "Back" button and try your operation again.

OR if the error persists and you require an email response
please contact us at "cs at curehunter.com":

Your request
The circumstances of the error
Your login id/nickname or email

Return to Top Page